A Study of a Multicomponent Intervention Aimed at Decreasing Perception of Dyspnea in Participants with Lung Disease Who are Obese

Overview

About this study

The purpose of this study is to define the feasibility and effectiveness of a multi-component intervention aimed at decreasing perception of dyspnea in participants with lung disease who are obese.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age ≥ 18 years.
BMI ≥ 35.
Dyspnea MRC class II or greater.
Diagnosis of lung disease.
Signed informed consent.

Exclusion Criteria:

BMI < 35.
Pregnancy.
Recent respiratory illness (within the last 6 weeks).
Recent exacerbation of chronic lung disease (within the last 6 weeks).
Already participating in a structured diet and/or exercise program.
Medical contraindication to weight loss (cancer).
Medical contraindication to unsupervised exercise (unstable angina).
People with implanted defibrillators or pacemakers (Although the electrical current that is sent through the body during the body composition scan is extremely low, it is not recommended for patients with implanted defibrillators or pacemakers)
People with implanted defibrillators or pacemakers (although the electrical current that is sent through the body during the body composition scan is extremely low, it is not recommended for patients with implanted defibrillators or pacemakers).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Roberto Benzo, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Roberto Benzo, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials